A rare case of systemic sclerosis that preceded the development of diabetes insipidus is reported. This 25-year-old manpresented with Raynaud's phenomenonand ulceration of the tip of the right thumb. The diagnosis of systemic sclerosis was based on findings of proximal scleroderma, sclerodactyly, serological abnormalities, and skin abnormalities verified histologically. Partial central diabetes insipidus was later diagnosed after the sudden appearance of polyuria and polydipsia. Coexistence of systemic sclerosis with diabetes insipidus suggests that diabetes insipidus in this patient might have occurred via an autoimmune mechanism. (Internal Medicine 36: 73-76, 1997) 
Introduction
Central diabetes insipidus is characterized by polyuria and polydipsia. These symptoms are due to a lack of arginine vasopressin, which is normally produced in the supraoptic and paraventricular nuclei of the hypothalamus. Central diabetes insipidus is classified as primary central diabetes insipidus and secondary central diabetes insipidus. Primary diabetes insipidus includes familial and idiopathic diabetes insipidus, and the secondary diabetes insipidus is caused by neoplasms, trauma, infectious diseases, vascular diseases, surgical treatment, or systemic diseases including sarcoidosis (1) . Previous studies suggest the involvement of autoimmunemechanismsin the pathogenesis of idiopathic diabetes insipidus in some patients (2) (3) (4) (5) (6) (7) (8) (9) (10) .
Systemic sclerosis is a generalized disorder of the connective tissue characterized by a thickening and fibrosis of the skin and by the involvement of the internal organs including heart, lungs, kidneys, and gastrointestinal tract (1 1). Systemic sclerosis is knownto overlap other autoimmunediseases, such as, systemic lupus erythematosus, polymyositis, rheumatoid arthritis, Sjogren' s syndrome, Hashimoto 's thyroiditis and primary biliary cirrhosis (1 1, 12 Table 1 ; these values include a white blood cell (WBC)count of 4,200/mm3, an erythrocyte sedimentation rate (ESR) of 2/h, and a C-reactive protein (CRP) concentration of 0.09 mg/dl. Coagulation tests including prothrombin time, hepaplastin test, plasma fibrinogen concentration, and plasma FDPconcentration were normal. Rheumatoidfactor was negative. Antinuclear antibody (discrete-speckled type) was identified (xl ,280). Anti-nRNP antibody, anti-Scl 70 antibody, and antiJo 1 antibody were negative. Anti-centromere antibody was strongly positive (x1 ,280). The serum immune complex level was normal. Cryoglobulin was not detected in the serum.
Urinalysis revealed no abnormality. A chest radiograph, roentgenogram of the fingers , and barium esophagram revealed no abnormality. A specimen of a skin biopsy from the forearm demonstrated a thin epidermis and an increase of collagen ( Fig.  1 ). Therefore, we diagnosed systemic sclerosis with limited cutaneous scleroderma, and the patient was treated with a calcium channel blocker (nilvadipine), an S2 serotonergic receptor antagonist (sarpogrelate hydrochloride) and a prostaglandin analogue (alprostadil). Despite such treatment, the Raynaud's phenomenonand the ulceration of the tip of the right thumb did not improve. Wethen performed sympathetic block, which led to improvement of the Raynaud's phenomenon and the digital tip ulceration. The patient suddenly developed polyuria and polydipsia. He passed between 4 and 8 / urine, free of glucose, per day for 16 days. Serum Na concentration was 145 mEq//. The basal level of plasma antidiuretic hormone (ADH) (0.5-3.5 pg/ml) was 0.9 pg/ml. In a dehydration test, he lost 1 kg in weight and passed 690 ml of urine. Then, plasma osmolality was 290 mOsm//, urine osmolality 574 mOsm//, and the plasma ADHconcentration was 0.8 pg/ml (Fig. 2) . After the subcutaneous injection of 5 units of vasopressin, the urine osmolality was 629 mOsm/l (Fig. 2) . Although the urine osmolality exceeded plasma osmolality and the serum concentration of ADHwas in the low normal range, the concentration of ADHwas low relative to plasma osmolality. Furthermore, the rise in urine osmolality after vasopressin administration exceeded 9%. Therefore, partial central diabetes insipidus was diagnosed (1, 13, 14) . The serum concentration of angiotensin converting enzyme (ACE) was 9.5 IU// (8.3-21.4 IU//). Hypofunction of the anterior pituitary was not documented (Table 2 ). Magnetic resonance imaging (MRI) in Tlweighted images revealed a decrease of high intensity signal in the posterior pituitary lobe, but no other abnormalities were found (Fig. 3) . The administration of desmopressin, intranasally
The patient was discharged, and has been followed up at our prostacyclin analogue (beraprost sodium).
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Discussion
The present patient was diagnosed with systemic sclerosis based on the presence of Raynaud's phenomenon,proximal scleroderma, sclerodactyly, serological abnormalities and histological findings (15). Raynaud's phenomenon and digital tip ulceration on the thumb were improved with treatment consisting of calcium channel blocker, S2 serotonergic receptor agonist, prostaglandin analogue, and sympathetic block. After the appearance of polyuria and polydipsia, the urine osmolality exceeded that of plasma. However, the plasma concentration of ADHwas rather low (0.8 pg/ml), even after water deprivation, when the plasma osmolality was 290 mOsm//. In the dehydration test, the rise in urinary osmolality after vasopressin administration exceeded 9% (9.6%). MRIrevealed a decrease of a high-intensity signal in the posterior pituitary lobe on Tlweighted image, as previously described by Tien (16 ducing cells, however, the association between diabetes insipidus and scleroderma suggested the possibility of an autoimmune mechanism.Because the coexistence of an established autoimmunedisease with an idiopathic endocrine disorder suggests the possibility of an autoimmune pathogenic mechanism of the latter (4). It is unlikely that the microvascular abnormality caused by scleroderma led to diabetes insipidus in this patient, because he had no other focal neurological abnormalities and systemic sclerosis usually spares the central nervous system (1 1). Various autoantibodies are present in the sera of patients with systemic sclerosis, and antinuclear antibodies are present in the sera of over 90%of patients with systemic sclerosis (1 1). Evidence of T lymphocyte activation has been seen in patients with systemic sclerosis (1 1 Hashimoto ' s disease and primary biliary cirrhosis are known to occur in overlap with systemic sclerosis (ll, 12). And antinuclear antibody and anti-centromere antibody were positive in the present patient. Therefore, autoimmunemechanisms might be involved in the pathogenesis of diabetes insipidus in the present case, although the authors were unable to demonstrate the pathological evidence. Whena large number of patients is studied, the association might becomesignificant. Further studies are required to elucidate the role of the immune,system in the pathogenesis of idiopathic diabetes insipidus.
